106 related articles for article (PubMed ID: 24991950)
1. It's not necessarily all about the delivery in Huntington's disease.
Parsons MP; Raymond LA
Neuron; 2014 Jul; 83(1):6-8. PubMed ID: 24991950
[TBL] [Abstract][Full Text] [Related]
2. Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington's disease.
Plotkin JL; Day M; Peterson JD; Xie Z; Kress GJ; Rafalovich I; Kondapalli J; Gertler TS; Flajolet M; Greengard P; Stavarache M; Kaplitt MG; Rosinski J; Chan CS; Surmeier DJ
Neuron; 2014 Jul; 83(1):178-88. PubMed ID: 24991961
[TBL] [Abstract][Full Text] [Related]
3. Early Downregulation of p75
Suelves N; Miguez A; López-Benito S; Barriga GG; Giralt A; Alvarez-Periel E; Arévalo JC; Alberch J; Ginés S; Brito V
Mol Neurobiol; 2019 Feb; 56(2):935-953. PubMed ID: 29804232
[TBL] [Abstract][Full Text] [Related]
4. Corticostriatal synaptic adaptations in Huntington's disease.
Plotkin JL; Surmeier DJ
Curr Opin Neurobiol; 2015 Aug; 33():53-62. PubMed ID: 25700146
[TBL] [Abstract][Full Text] [Related]
5. 7,8-dihydroxyflavone ameliorates cognitive and motor deficits in a Huntington's disease mouse model through specific activation of the PLCγ1 pathway.
García-Díaz Barriga G; Giralt A; Anglada-Huguet M; Gaja-Capdevila N; Orlandi JG; Soriano J; Canals JM; Alberch J
Hum Mol Genet; 2017 Aug; 26(16):3144-3160. PubMed ID: 28541476
[TBL] [Abstract][Full Text] [Related]
6. Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease.
Ma Q; Yang J; Li T; Milner TA; Hempstead BL
Neurobiol Dis; 2015 Oct; 82():466-477. PubMed ID: 26282324
[TBL] [Abstract][Full Text] [Related]
7. Impaired development of cortico-striatal synaptic connectivity in a cell culture model of Huntington's disease.
Buren C; Parsons MP; Smith-Dijak A; Raymond LA
Neurobiol Dis; 2016 Mar; 87():80-90. PubMed ID: 26711622
[TBL] [Abstract][Full Text] [Related]
8. TRiC subunits enhance BDNF axonal transport and rescue striatal atrophy in Huntington's disease.
Zhao X; Chen XQ; Han E; Hu Y; Paik P; Ding Z; Overman J; Lau AL; Shahmoradian SH; Chiu W; Thompson LM; Wu C; Mobley WC
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5655-64. PubMed ID: 27601642
[TBL] [Abstract][Full Text] [Related]
9. Functional interactions within striatal microcircuit in animal models of Huntington's disease.
Ghiglieri V; Bagetta V; Calabresi P; Picconi B
Neuroscience; 2012 Jun; 211():165-84. PubMed ID: 21756979
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington's disease models.
Li W; Silva HB; Real J; Wang YM; Rial D; Li P; Payen MP; Zhou Y; Muller CE; Tomé AR; Cunha RA; Chen JF
Neurobiol Dis; 2015 Jul; 79():70-80. PubMed ID: 25892655
[TBL] [Abstract][Full Text] [Related]
11. Divergent regulatory mechanisms governing BDNF mRNA expression in cerebral cortex and substantia nigra in response to striatal target ablation.
Rite I; Machado A; Cano J; Venero JL
Exp Neurol; 2005 Mar; 192(1):142-55. PubMed ID: 15698628
[TBL] [Abstract][Full Text] [Related]
12. Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation.
Miguez A; García-Díaz Barriga G; Brito V; Straccia M; Giralt A; Ginés S; Canals JM; Alberch J
Hum Mol Genet; 2015 Sep; 24(17):4958-70. PubMed ID: 26063761
[TBL] [Abstract][Full Text] [Related]
13. AAV1/2-mediated BDNF gene therapy in a transgenic rat model of Huntington's disease.
Connor B; Sun Y; von Hieber D; Tang SK; Jones KS; Maucksch C
Gene Ther; 2016 Mar; 23(3):283-95. PubMed ID: 26704721
[TBL] [Abstract][Full Text] [Related]
14. Relationship between BDNF expression in major striatal afferents, striatum morphology and motor behavior in the R6/2 mouse model of Huntington's disease.
Samadi P; Boutet A; Rymar VV; Rawal K; Maheux J; Kvann JC; Tomaszewski M; Beaubien F; Cloutier JF; Levesque D; Sadikot AF
Genes Brain Behav; 2013 Feb; 12(1):108-24. PubMed ID: 23006318
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of apoptosis signal-regulating kinase 1 reduces endoplasmic reticulum stress and nuclear huntingtin fragments in a mouse model of Huntington disease.
Cho KJ; Lee BI; Cheon SY; Kim HW; Kim HJ; Kim GW
Neuroscience; 2009 Nov; 163(4):1128-34. PubMed ID: 19646509
[TBL] [Abstract][Full Text] [Related]
16. Connectivity-based segmentation of the striatum in Huntington's disease: vulnerability of motor pathways.
Bohanna I; Georgiou-Karistianis N; Egan GF
Neurobiol Dis; 2011 Jun; 42(3):475-81. PubMed ID: 21382492
[TBL] [Abstract][Full Text] [Related]
17. The corticostriatal pathway in Huntington's disease.
Cepeda C; Wu N; André VM; Cummings DM; Levine MS
Prog Neurobiol; 2007 Apr; 81(5-6):253-71. PubMed ID: 17169479
[TBL] [Abstract][Full Text] [Related]
18. Reduced activity of cortico-striatal fibres in the R6/2 mouse model of Huntington's disease.
Traficante A; Riozzi B; Cannella M; Rampello L; Squitieri F; Battaglia G
Neuroreport; 2007 Dec; 18(18):1997-2000. PubMed ID: 18007201
[TBL] [Abstract][Full Text] [Related]
19. Intrastriatal CERE-120 (AAV-Neurturin) protects striatal and cortical neurons and delays motor deficits in a transgenic mouse model of Huntington's disease.
Ramaswamy S; McBride JL; Han I; Berry-Kravis EM; Zhou L; Herzog CD; Gasmi M; Bartus RT; Kordower JH
Neurobiol Dis; 2009 Apr; 34(1):40-50. PubMed ID: 19150499
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of BDNF and Full-Length TrkB Receptor Ameliorate Striatal Neural Survival in Huntington's Disease.
Silva A; Naia L; Dominguez A; Ribeiro M; Rodrigues J; Vieira OV; Lessmann V; Rego AC
Neurodegener Dis; 2015; 15(4):207-18. PubMed ID: 25896770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
